To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Automated Bone Scan Index… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.

Journal article
Authors Aseem Anand
Michael J Morris
Steven M Larson
David Minarik
Andreas Josefsson
John T Helgstrand
Peter S Oturai
Lars Edenbrandt
Martin Andreas Røder
Anders Bjartell
Published in EJNMMI research
Volume 6
Issue 1
Pages 23
ISSN 2191-219X
Publication year 2016
Published at Institute of Clinical Sciences, Department of Urology
Pages 23
Language en
Subject categories Cancer and Oncology, Urology and Nephrology


Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?